Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis

Published:2017-10-26 Issue:1 Volume:31 Page:
ISSN:1120-8694
Container-title:Diseases of the Esophagus
language:en
Short-container-title:

Author:

Tie H,He F,Shen J,Zhang B,Ye M,Chen B,Wu Q

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/dote/article-pdf/31/1/dox116/23893280/dox116.pdf

Reference38 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin 2016

2. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus;Bosset;N Engl J Med,1997

3. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781;Tepper;J Clin Oncol,2008

4. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

5. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis;Gebski;Lancet Oncol,2007

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the interval between neoadjuvant immunotherapy and surgery on prognosis in esophageal squamous cell carcinoma (ESCC): a real-world study;Cancer Immunology, Immunotherapy;2024-08-06

2. Changes in the gut microbiome of patients with esophageal cancer: A systematic review and meta-analysis based on 16S gene sequencing technology;Microbial Pathogenesis;2024-08

3. The Society of Thoracic Surgeons/American Society for Radiation Oncology/American Society of Clinical Oncology Recommendations on the Care of Patients With Localized Esophageal Cancers;Journal of Cardiothoracic and Vascular Anesthesia;2024-07

4. Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma?;Journal of Cancer Research and Clinical Oncology;2024-03-27

5. The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction;The Annals of Thoracic Surgery;2024-01